Lupin gets USFDA nod for Asthma drug

The product approved by the United States Food and Drug Administration (USFDA) is a generic version of AstraZeneca Pharmaceuticals LP’s Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL, Lupin said in a regulatory filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/lupin-gets-usfda-nod-for-asthma-drug/66603275?utm_source=RSS&utm_medium=ETRSS

Related Posts